Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccination

Article Immunology

Autoimmune phenomena following SARS-CoV-2 vaccination

Yuval Ishay et al.

Summary: Vaccines are seen as a potential solution to the COVID-19 pandemic, but widespread distribution has been hindered by concerns over side effects. In Israel, where a large percentage of the population has been vaccinated, cases of autoimmune conditions following vaccination have been observed, but they generally have mild symptoms requiring modest treatment.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

添加到收藏夹

Letter Medicine, General & Internal

Severe Exacerbations of Systemic Capillary Leak Syndrome After COVID-19 Vaccination: A Case Series

Meghan Matheny et al.

ANNALS OF INTERNAL MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

New-onset IgG autoantibodies in hospitalized patients with COVID-19

Sarah Esther Chang et al.

Summary: In hospitalized COVID-19 patients, approximately 50% have detectable autoantibodies primarily targeting autoantigens associated with rare disorders. Additionally, a subset of autoantibodies develop de novo following SARS-CoV-2 infection.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Letter Dermatology

Systemic lupus erythematosus after COVID-19 vaccination: A case report

Sakshi Patil et al.

JOURNAL OF COSMETIC DERMATOLOGY (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Reactive arthritis after COVID-19 vaccination

Qi-jun An et al.

Summary: Reactive arthritis (ReA) following COVID-19 vaccination is rare but the benefits of vaccination outweigh potential risks. Future attention should focus on identifying individuals at higher risk for developing autoimmune diseases after COVID-19 vaccination and exploring more versatile and safer vaccines.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

添加到收藏夹

Article Immunology

Fatal Multisystem Inflammatory Syndrome in Adult after SARS-CoV-2 Natural Infection and COVID-19 Vaccination

Heather N. Grome et al.

Summary: This case describes a fatal instance of multisystem inflammatory syndrome in an adult occurring 22 days after receiving the second dose of an mRNA coronavirus vaccine. Both serologic and clinical findings suggested the infection of SARS-CoV-2 happened before the vaccination. The immunopathology of this syndrome, regardless of vaccination status, is still poorly understood.

EMERGING INFECTIOUS DISEASES (2021)

添加到收藏夹

Review Medicine, General & Internal

Multisystem Inflammatory Syndrome in an Adult after COVID-19 Vaccination: a Case Report and Literature Review

Jung Wan Park et al.

Summary: Increasing number of people vaccinated are experiencing adverse reactions, including a case of multisystem inflammatory syndrome (MIS) after ChAdOx1 COVID-19 vaccination, characterized by low blood pressure, fever, edema, and systemic inflammation. Prompt diagnosis and treatment are crucial in managing MIS post COVID-19 vaccination.

JOURNAL OF KOREAN MEDICAL SCIENCE (2021)

添加到收藏夹

Review Rheumatology

COVID-19 and systemic sclerosis: Rising to the challenge of a pandemic

Christopher P. Denton et al.

Summary: COVID-19, caused by the novel coronavirus SARS-CoV-2, has posed significant challenges to healthcare and political systems globally, impacting diseases like systemic sclerosis. The pandemic led to the postponement of the Sixth Systemic Sclerosis World Congress and highlighted potential avenues for improving systemic sclerosis care in the future through necessary adjustments due to the pandemic.

JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2021)

添加到收藏夹

Article Rheumatology